Your browser doesn't support javascript.
loading
A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
Kuwatsuru, Ryohei; Takahashi, Satoru; Umeoka, Shigeaki; Sugihara, Ryo; Zeng, Mengsu; Huan, Yi; Peng, Weijun; Ma, Lin; Guo, Liang; Teng, Gaojun; Yao, Weiwu; Tozaki, Mitsuhiro; Endo, Masahiro; Kaji, Shuichiro; Ro, Tokugen; Tae Hahn, Seong; Chul Kang, Byung; Nishimura, Hiroshi; Sugawara, Yoshifumi; Katakami, Nobuyuki; Breuer, Josy; Aitoku, Yasuko.
Affiliation
  • Kuwatsuru R; Department of Radiology, Juntendo University, Faculty of Medicine, Tokyo, Japan.
J Magn Reson Imaging ; 41(2): 404-13, 2015 Feb.
Article in En | MEDLINE | ID: mdl-24692302
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Magnetic Resonance Imaging / Contrast Media / Gadolinium DTPA Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2015 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Magnetic Resonance Imaging / Contrast Media / Gadolinium DTPA Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Year: 2015 Type: Article